Full Press Release Details
Pipeline Update.
TGTX
Pipeline Update
Key Takeaway: Pipeline Update
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+40%
120-day peak, hindsight
Typical move
10.5%
average across 4 past catalysts
Lead asset
Ublituximab
Phase 3 · Relapsing Multiple Sclerosis